MedTrace Logo

Utilizing Blood Volume Measurements in the Treatment of Heart Failure Patients

NCT00861770 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-05-11

No results posted yet for this study

Summary

This will be a clinical test to determine if using blood volume measurements (BVM) to help guide fluid removal with ultrafiltration in patients hospitalized with decompensated heart failure leads to improved outcomes.

Conditions

  • Congestive Heart Failure

Interventions

OTHER

Ultrafiltration

Ultrafiltration based on standard of care.

OTHER

Ultrafiltration using BVM

Ultrafiltration will be guided by blood volume measurement results.

Sponsors & Collaborators

  • Daxor Corporation

    collaborator INDUSTRY

  • Christiana Care Health Services

    lead OTHER

Principal Investigators

  • Mitchell Saltzberg, MD, FACC · Christiana Care Health Services

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00861770 on ClinicalTrials.gov